Priorix Kit
Product Images NDC 58160-824

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Priorix (NDC 58160-824). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glaxosmithkline Biologicals Sa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Priorix Spl Graphic 01)

An instructional diagram showing two hands assembling a syringe and a vial adapter by twisting the adapter onto the syringe tip, illustrating the connection process for preparation or administration.*

FDA Label Image

Figure 2 (Priorix Spl Graphic 02)

An instructional diagram showing a syringe labeled 'Sterile Water Diluent' inserted into a vial labeled 'Lyophilized Antigen Component.' An arrow points downward indicating the syringe injecting the diluent into the vial, illustrating the reconstitution step for the Priorix vaccine kit by GlaxoSmithKline Biologicals SA.*

FDA Label Image

Figure 3 (Priorix Spl Graphic 03)

An instructional illustration showing a hand holding a vial and syringe, demonstrating a shaking or mixing motion with arrows indicating side-to-side and rotational movement. This likely depicts the step of mixing the vaccine in the vial before administration.*

FDA Label Image

Figure 4 (Priorix Spl Graphic 04)

An instructional illustration showing a vial connected to a syringe with a needle, labeled 'Reconstituted Vaccine.' The image depicts the reconstitution process of a vaccine by drawing liquid from the vial into the syringe, indicated by a downward pointing arrow below the syringe.*

FDA Label Image

Priorix 10 Dose Carton (Priorix Spl Graphic 05)

Packaging label for Priorix Measles, Mumps, and Rubella Vaccine, Live, a vaccine kit by GlaxoSmithKline Biologicals SA. The label states it contains 10 doses of lyophilized antigen component and sterile water diluent for reconstitution, intended for subcutaneous injection. The vaccine is for use in individuals 12 months of age and older.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.